The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Google Chrome
Safari
Firefox
Edge
© 2025 Hovione
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
search
    en
      pt jp cn
Hovione
Home Go up
  • Products and Services
      • Contract Manufacturing Services
        • Drug Substance
        • Particle Engineering
        • Drug Product
      • Off-patent API products
        • API Portfolio
        • Exclusive partnerships
        • High value applications
      • Supporting Capabilities
        • Analytical Support
        • Capabilities
        • Continuity of Supply
        • Quality and Compliance
  • Knowledge Center
  • About Us
      • About Hovione
        • What we do
        • Management
        • Sustainability
        • History
  • Contact Us
  • Press Room
  • Hovione Worldwide
  • Careers
  • Restricted Area

Search

Types

  • Article

Press Room

  • Press Release
  • Article
  • Press Clipping

Categories

  • Hovione New Jersey
  • Hovione Cork
  • Hovione Loures
  • Hovione Lumiar
  • PE - Particle Engineering
  • DP - Drug product
  • Hovione Japan
  • Continuous Manufacturing
  • DS - Drug Substance
  • PE - Spray drying
  • Hovione Mumbai
  • Continuous Tableting
  • Dispersome
  • Hovione Macau
  • Hovione Shanghai
  • asd-hipros
  • Compliance
  • Continuous Flow
  • Development by Design
  • Devices
  • DP - Capsule filling
  • DP - Formulation of amorphous systems
  • DP - Tableting
  • Integrated Offering
  • Manufacturing
  • Off-patent API
  • PAT
  • PE - Drug delivery platforms
  • PE - Spray congealing
  • Quality
  • Quality by Design
  • (-) Contract Manufacturing Services
  • (-) Homepage
View
Press Release / Nov 22, 2021

Hovione announces New Pharma Campus expansion in New Jersey

This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy

View
Article / Oct 10, 2022

Hovione’s Continuous Manufacturing Facility, Loures, Portugal

Pharmaceutical Technology, 10 October 2022

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Current page 2
Analytical Support
Quality and Compliance
Capabilities
Continuity of Supply
Track Record/cGMP Compliance
Regulatory Affairs
Continuity of Supply
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
Contacts
Lindenstrasse 14
6340 Baar
Switzerland
  • Linkedin
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • Privacy Notice
  • Terms and Conditions
    • Linkedin
    • Facebook
    • Twitter
    • Instagram
    • Youtube
  • Hovione Worldwide
  • Events
  • Press Room
  • Careers
  • Customers
  • Suppliers
  • Contacts
    Lindenstrasse 14
    6340 Baar
    Switzerland
    © 2025 Hovione
    © 2025 Hovione
    • Privacy Notice
    • Terms and Conditions